Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Kerry's toxic drug plan
Robert Goldberg, Ph.D., Washington Times, 10-22-04

Robert Goldberg, a Senior Fellow at the Manhattan Institute, writes that Senator Kerry's indictment of the Bush Administration for the current flu vaccine shortage smacks of hypocrisy and worse an unsustainable prescription drug policy. Currently, the government uses its purchasing power to push vaccine prices below cost, crippling vaccine R&D and driving producers out of the market. If he becomes President, Goldberg warns that Kerry would use the same failed policies to cripple the entire pharmaceutical industry: "price controls, bulk purchase, and importation of medicines are exactly the policies that have pushed the vaccine industry to the brink of extinction" and are the same policies that Kerry advocates for the entire healthcare sector.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000